**What's Known**

Appropriate initiation time of renal replacement treatment in ICU patients is not known.There is a paucity of relevant data in the existing literature.

**What's New**

Our study is the first study to evaluate the initiation time of RRT according to the RIFLE and AKIN classifications in the ICU.

Introduction {#sec1-1}
============

Acute kidney injury (AKI) is a sudden deterioration of renal functions. It can be defined as an increase in the serum creatinine of 0.3 mg/dL in 48 hours or a 1.5-fold increase compared to the baseline value in 7 days or urine output \<0.5 mL/kg/h for over 6 hours. The incidence of AKI is between 5% and 60% in the intensive care unit (ICU). Five to ten percent of critically ill patients with AKI require hemodialysis (HD) to support their fluid and metabolic balances.^[@ref1]-[@ref3]^

The HD initiation criteria are clearly defined in patients with chronic renal disease. However, in AKI, some specialists tend to start HD late (after 2 or more definite criteria have occurred), while others tend to start it early (only 1 criterion as hypervolemia or acidosis). In the literature, there are different parameters to define the timing of HD.^[@ref2]-[@ref4]^

The classifications of RIFLE (Risk, Injury, Failure, Loss, and End-stage renal failure) and AKIN (Acute Kidney Injury Network) have been developed to determine the diagnosis and prognosis in AKI. These classifications, which are based on the increase in serum creatinine and decrease in the global filtration rate (GFR) and urine output, have been used to determine the time to start HD and to predict mortality in AKI.^[@ref4],[@ref5]^

The aim of the present study was to define the criteria for HD initiation in our medical ICU patients and to determine the effects of early vs. late HD initiation according to the RIFLE and AKIN classifications on ICU mortality.

Patients and Methods {#sec1-2}
====================

Sixty-eight patients who were admitted to the Medical ICU of Gazi University Hospital between January 2009 and August 2014 and underwent HD during their ICU stay were included in this retrospective study. The ethics committee of our institution approved the study (\#25901600/79, decision date: 01.29.2015). Patients with chronic renal disease, HD initiation before ICU admission, and ICU stay \<48 hours were excluded from the study.

The demographics of the patients; ICU admission reasons; comorbidities; severity scores; etiologies of AKI; levels of blood urea, creatinine, sodium, potassium, phosphorus, albumin, blood pH, and bicarbonate; urine outputs; estimated GFRs; and RIFLE and AKIN classes at admission and immediately before the initiation of HD were recorded retrospectively. The Cockcroft--Gault formula was used to calculate the estimated GFR. The values were normalized for a body surface area of 1.73 m^2^ and gender. Additional morbidities during ICU stay (mechanical ventilation support, development of sepsis/septic shock, etc.) and mortality were recorded. The patients were divided into 2 groups of surviving and deceased. The patients with no risk, risk, and injury according to RIFLE and in stage 0, I, or II according to AKIN were defined as early HD and the patients in failure stage according to RIFLE and in stage III according to AKIN were defined as late HD. The differences in ICU mortality were compared between the early and late HD groups.

*Statistical Analysis* {#sec2-1}
----------------------

SPSS, version 17 (SPSS Inc., Chicago, IL, USA), was used in the statistical analyses. The Mann--Whitney *U*-test and the χ^2^ test were employed in the comparisons. The parameters that were significant in the univariate analysis were included in the logistic regression analysis, and the independent risk factors were defined for ICU mortality. P values \<0.05 were considered statistically significant.

Results {#sec1-3}
=======

A total of 2183 patients were admitted to our ICU during the study period, and 311 of them received HD. After the application of the exclusion criteria, 68 patients were included in the study. The median age of the patients was 66.5 years, and 56.5% of them were male. The rates of intermittent and continuous HD were 63.2% and 50%, respectively. The most common indications for HD initiation were decreased urinary output (70.6%), estimated GFR\<30 mL/min (66.2%), and hypervolemia due to congestive heart failure (50%). HD was started in 25% of the patients in the early stage according to the RIFLE classification, while HD was commenced in 39.7% of the patients in the early stage according to the AKIN classification.

At the end of the study period, 19.1% of the patients survived and 80.9% of them died. The rates of HD initiation in the early stage according to the RIFLE classification of the surviving and deceased groups were 61.5% and 16.4%, correspondingly (P=0.001). The rates of HD initiation in the early stage according to the AKIN classification in the surviving and deceased groups were 69.2% and 32.7%, respectively (P=0.026). The rates of sepsis (61.5% vs. 94.5%; P=0.001) and mechanical ventilation support (30.8% vs. 87.3%; P\<0.001) during HD were higher in the deceased group. The rates of intermittent HD were 92.3% and 56.4% in the surviving and deceased groups, correspondingly (P=0.016).

There was no difference in ICU mortality between the groups according to creatinine levels\<3 mg/dL and ≥3 mg/dL (30.8% vs. 29.1%; P=0.935) and blood urea nitrogen≥100 mg/dL and \<100 mg/dL (7.7% vs. 32.7%; P=0.342) at the time of HD initiation ([table 1](#T1){ref-type="table"}).

###### 

General characteristics of all, surviving and deceased, patients in the study population

  Parameters                                                         All patients (N=68)   Surviving patients (n=13)   Deceased patients (n=55)   P value
  ------------------------------------------------------------------ --------------------- --------------------------- -------------------------- ---------
  Age (y) (median, interquartile range)                              66.5 (54-76.8)        69 (47-80)                  66 (55-75)                 0.963
  Gender (male, %)                                                   39 (56.5)             4 (30.8)                    35 (63.6)                  0.059
  Length of ICU stay (d) (median, interquartile range)               10.5 (5-21)           7 (5-17)                    12 (5-26)                  0.232
  Length of hospital stay (d) (median, interquartile range)          20.5 (13.3-33.5)      20 (10-24.5)                21 (13-37)                 0.454
  APACHE II score (median, interquartile range)                      24 (18.3-28)          20 (11-24)                  25 (19-29)                 0.020
  SOFA score on admission (median, interquartile range)              7 (5-11)              5 (4-8)                     8 (6-12)                   0.003
  SOFA score on discharge (median, interquartile range)              14 (9-17)             4 (2.5-6)                   15 (10-18)                 \<0.001
  Charlson comorbidity score (median, interquartile range)           3 (2-4)               3 (2.5-4)                   2 (2-4)                    0.42
  Reasons for admission to the ICU (n, %)                                                                                                         
   Respiratory insufficiency                                         46 (67.6)             9 (69.2)                    37 (67.3)                  0.892
   Sepsis/septic shock                                               46 (67.6)             5 (38.5)                    41 (74.5)                  0.012
   Cardiovascular                                                    10 (14.7)             2 (15.4)                    8 (14.5)                   0.939
   Gastrointestinal                                                  16 (23.5)             2 (15.4)                    14 (25.5)                  0.441
   Renal                                                             28 (41.2)             7 (53.8)                    21 (38.2)                  0.357
  Comorbidities (n, %)                                                                                                                            
   Diabetes mellitus                                                 19 (28)               3 (23.1)                    16 (29.1)                  0.664
   Cardiovascular                                                    27 (39.7)             6 (46.2)                    21 (38.2)                  0.754
   Hypertension                                                      32 (47.1)             8 (61.5)                    24 (43.6)                  0.356
   Cancer                                                            30 (44.1)             4 (30.8)                    26 (47.3)                  0.36
   Respiratory (COPD)                                                13 (19.1)             7 (53.8)                    6 (11)                     \<0.001
   Gastrointestinal                                                  8 (11.8)              1 (7.7)                     7 (12.7)                   0.612
   Neurological                                                      11 (16.2)             2 (15.4)                    9 (16.4)                   0.931
  RIFLE classes on admission (n, %)                                                                                                               
   No risk                                                           19 (27.9)             1 (7.7)                     18 (32.7)                  0.07
   Risk                                                              24 (35.3)             7 (53.8)                    17 (30.9)                  0.12
   Injury                                                            25 (36.8)             5 (38.5)                    20 (36.4)                  0.888
  AKIN stages on admission (n, %)                                                                                                                 
   AKIN 0                                                            21 (30.4)             1 (7.7)                     20 (36.4)                  0.044
   AKIN I                                                            27 (39.1)             8 (61.5)                    19 (34.5)                  0.114
   AKIN II                                                           20 (29.4)             4 (30.8)                    16 (29.1)                  0.905
  Possible causes of AKI (n, %)                                                                                                                   
   Sepsis                                                            39 (57.4)             2 (15.4)                    37 (67.3)                  0.001
   Colistin usage                                                    9 (13.2)              0                           9 (16.4)                   0.117
   Diuretics                                                         10 (14.7)             2 (15.4)                    8 (14.5)                   0.939
   Amphotericin B                                                    4 (5.8)               0                           4 (7.3)                    0.316
   Acyclovir usage                                                   3 (4.4)               0                           3 (5.5)                    0.389
   Hypervolemia                                                      4 (5.8)               3 (23.1)                    1 (1.8)                    0.003
   Radiocontrast agent                                               5 (7.4)               1 (7.7)                     4 (7.3)                    0.958
  HD modalities (n, %)                                                                                                                            
   Intermittent HD                                                   43 (63.2)             12 (92.3)                   31 (56.4)                  0.016
   Continuous HD                                                     34 (50)               2 (15.4)                    32 (58.2)                  0.011
  Reasons for HD initiation (n, %)                                                                                                                
   BUN≥100 mg/dL                                                     19 (27.9)             1 (7.7)                     18 (32.7)                  0.342
   Potassium≥6 mEq/L                                                 6 (8.8)               0                           6 (11)                     0.251
   Hypervolemia                                                      34 (50)               7 (53.8)                    27 (49.1)                  1
   Creatinine≥3 mg/dL                                                20 (29.4)             4 (30.8)                    16 (29.1)                  0.935
   Hyperuricemia                                                     3 (4.4)               0                           3 (5.5)                    0.410
   Intoxication                                                      1 (1.5)               0                           1 (1.8)                    0.624
   pH\<7.20                                                          18 (26.5)             2 (15.4)                    16 (29.1)                  0.911
   Phosphorus≥7 mg/dL                                                6 (8.8)               0                           6 (11)                     0.237
   Refractory hypernatremia(≥150 mEq/L)                              9 (13.2)              1 (7.7)                     8 (14.5)                   0.725
   Severe metabolic acidosis (bicarbonate\<15 mEq/L with pH\<7.20)   26 (38.2)             1 (7.7)                     25 (45.5)                  0.012
   Lactate≥4 mEq/L                                                   10 (14.7)             0                           10 (18.2)                  0.143
   GFR\<30 mL/min                                                    45 (66.2)             9 (69.2)                    36 (65.5)                  0.796
   Urine output\<0.5 mL/kg/h                                         48 (70.6)             6 (46.2)                    42 (76.4)                  0.066
   Uremic encephalopathy                                             2 (2.9)               0                           2 (3.6)                    0.485
  RIFLE classes at the time of HD initiation (n, %)                                                                                               
   No risk                                                           3 (4.4)               1 (7.7)                     2 (3.6)                    0.522
   Risk                                                              7 (10.3)              3 (23.1)                    4 (7.3)                    0.092
   Injury                                                            7 (10.3)              4 (30.8)                    3 (5.5)                    0.007
   Failure                                                           49 (72.1)             5 (38.5)                    44 (80)                    0.003
   Loss                                                              2 (2.9)               0                           2 (3.6)                    0.485
   No risk, risk, injury (total)                                     17 (25)               8 (61.5)                    9 (16.4)                   0.001
  AKIN stages on HD initiation (n, %)                                                                                                             
   0                                                                 4 (5.8)               1 (7.7)                     3 (5.5)                    0.758
   I                                                                 6 (8.8)               3 (23.1)                    3 (5.5)                    0.044
   II                                                                17 (25)               5 (38.5)                    12 (21.8)                  0.213
   III                                                               41 (60.3)             4 (30.8)                    37 (67.3)                  0.026
   0, I, and II (total)                                              27 (39.7)             9 (69.2)                    18 (32.7)                  0.026
  Mechanical ventilation during HD                                   52 (76.5)             4 (30.8)                    48 (87.3)                  \<0.001
  Sepsis during HD                                                   60 (88.2)             8 (61.5)                    52 (94.5)                  0.001

ICU: Intensive care unit; APACHE II Score: Acute physiology and chronic health evaluation II score; SOFA Score: Sequential organ failure assessment score; COPD: Chronic obstructive pulmonary diseases; RIFLE, Risk, Injury, Failure, Loss, and End-stage renal failure; AKIN, Acute Kidney Injury Network; HD: Hemodialysis; AKI: Acute Kidney Injury; BUN: Blood urea nitrogen; GFR, Global filtration rate

The length of the ICU stay of the patients that received HD in the early stage according to the RIFLE and AKIN classifications (6 vs. 14, P=0.008 RIFLE; 7 vs. 15, P=0.002 AKIN) was shorter than that of the patients who received HD in the late stages according to RIFLE and AKIN ([table 2](#T2){ref-type="table"}).

###### 

Comparison of early and late HD groups according to the RIFLE and AKIN classifications

  Parameters                                             All patients (N=68)   Early HD (according to RIFLE) 17 (25%)   Late HD (according to RIFLE) 51 (75%)   P value   Early HD (according to AKIN) 27 (39,7%)   Late HD (according to AKIN) 41 (60,3%)   P value
  ------------------------------------------------------ --------------------- ---------------------------------------- --------------------------------------- --------- ----------------------------------------- ---------------------------------------- ---------
  Age (y) (median, interquartile range)                  66.5 (54-76.8)        58 (39.5-70.5)                           68 (57-78)                              0,062     64 (44-72)                                70 (57.5-79)                             0.114
  Gender (male, %)                                       39 (56.5)             8 (47.1)                                 31 (60.8)                               0.322     14 (51.9)                                 25 (61)                                  0.617
  Length of ICU stay (d) (median, interquartile range)   10.5 (5-21)           6 (2-16)                                 14 (6-26)                               0.008     7 (3-12)                                  15 (7.5-27.5)                            0.002
  APACHE II (median, interquartile range)                24 (18.3-28)          24 (17-33)                               24 (19-28)                              0.580     25 (18-31)                                23 (19-28)                               0.411
  SOFA score (median, interquartile range)               7 (5-11)              6 (4-6)                                  8 (5-11)                                0.216     7 (4-10)                                  8 (5-11)                                 0.293
  Reasons for admission to the ICU (n, %)                                                                                                                                                                                                                    
   Respiratory insufficiency                             46 (67.6)             11 (64.7)                                35 (68.6)                               0.772     18 (66.7)                                 28 (68.3)                                1.000
   Sepsis/septic shock                                   46 (67.6)             9 (52.9)                                 37 (72.5)                               0.148     17 (63)                                   29 (70.7)                                0.599
   Cardiovascular                                        10 (14.7)             1 (5.9)                                  9 (17.6)                                0.236     4 (14.8)                                  6 (14.6)                                 0.984
   Gastrointestinal                                      16 (23.5)             3 (17.6)                                 13 (25.5)                               0.509     6 (22.2)                                  10 (24.4)                                0.837
   Renal                                                 28 (41.2)             11 (64.7)                                17 (33.3)                               0.044     14 (51.9)                                 14 (34.1)                                0.208
  Comorbidities (n, %)                                                                                                                                                                                                                                       
   Diabetes mellitus                                     19 (28)               4 (23.5)                                 15 (29.4)                               0.640     6 (22.2)                                  13 (31.7)                                0.425
   Cardiovascular                                        27 (39.7)             4 (23.5)                                 23 (45.1)                               0.156     9 (33.3)                                  18 (43.9)                                0.453
   Hypertension                                          32 (47.1)             6 (35.3)                                 26 (51)                                 0.401     9 (33.3)                                  23 (56.1)                                0.085
   Cancer                                                30 (44.1)             9 (52.9)                                 21 (41.2)                               0.415     13 (48.1)                                 17 (41.5)                                0.625
   Respiratory (chronic obstructive lung diseases)       13 (19.1)             4 (23.5)                                 9 (17.6)                                0.593     6 (22.2)                                  7 (17.1)                                 0.754
   Gastrointestinal                                      8 (11.8)              2 (11.8)                                 6 (11.8)                                0.844     3 (11.1)                                  5 (12.2)                                 0.705
   Neurological                                          11 (16.2)             1 (5.9)                                  10 (19.6)                               0.183     2 (7.4)                                   9 (22)                                   0.111
  Mechanical ventilation during HD (n, %)                52 (76.5)             9 (52.9)                                 43 (84.3)                               0.018     18 (66.7)                                 34 (82.9)                                0.150
  Sepsis during HD (n, %)                                60 (88.2)             14 (82.4)                                46 (90.2)                               0.385     22 (81.5)                                 38 (92.7)                                0.161
  Mortality in the ICU (n, %)                                                  9 (52.9)                                 46 (90.2)                               0.001     18 (66.7)                                 37 (90.2)                                0.026

HD: Hemodialysis; ICU: Intensive care unit; APACHE II Score: Acute physiology and chronic health evaluation II score; SOFA Score: Sequential organ failure assessment score; RIFLE, Risk, Injury, Failure, Loss, and End-stage renal failure; AKIN: Acute Kidney Injury Network

In the multivariate analysis, HD initiation in the early stage according to the RIFLE classification was found to be an independent factor in the decreased ICU mortality (OR=0.7, 95% CI=0.008--0.62; P=0.017). Mechanical ventilation support (OR=12.35, 95% CI=1.78--85.8; P=0.011) and sepsis (OR=22.36, 95% CI=1.5--333.3; P=0.024) were the factors that increased ICU mortality during HD.

Discussion {#sec1-4}
==========

In the literature, there are a large number of studies on the timing of renal replacement therapy (RRT) in AKI, especially in critically ill patients. Studies on the evaluation of the RIFLE and AKIN criteria vis-à-vis HD initiation are very limited. In our study, we hypothesized that early initiation of RRT in critically ill patients according to the RIFLE and AKIN classifications decreases ICU mortality. We found that early HD initiation according to the RIFLE classification decreased ICU mortality. Additionally, we found that sepsis and mechanical ventilation during RRT were bad prognostic factors for mortality during HD.

According to a study from Canada, life-threatening high serum potassium levels, presence of pulmonary edema due to hypervolemia, and severity of edema are the criteria considered by clinicians during HD initiation.^[@ref6]^ In our study, decreased urinary output, decreased GFR (\<30 mL/min), and hypervolemia were the most common reasons for HD initiation.

In a study by Shiao et al.,^[@ref7]^ the rate of mortality was decreased in a situation where HD was started when the serum creatinine value was 1.5--2-fold compared to when the serum creatinine level was more than twofold the normal value. Elsewhere, the mortality rate was reported to show an increase in patients who were started on HD when their creatinine levels were \<3.5 mg/dL (309 μmol/L).^[@ref8],[@ref9]^ In our study, we did not find any difference in mortality between the low creatinine group (\<3 mg/dL) and the high creatinine group (≥3 mg/dL), suggesting that creatinine levels was not a major determinative parameter for HD initiation in our ICU.

The blood urea level has been noted to play a role in the timing of HD and the prognosis of the patients in some studies, while it was not significant in the studies performed by Jamale et al.^[@ref10]^ and Demirkilic et al.^[@ref11]^ Similar to these studies, we did not find any difference in ICU mortality according to the blood urea level.

Oliguria was selected as a criterion to start RRT in many studies, and this was found to be more sensitive than urea or creatinine levels in predicting the prognosis.^[@ref12]^ Oliguria was defined as \<100 mL of urine in 8 hours, \<400 mL of urine in 24 hours, or \<30 mL of urine hourly in 6 hours. In our study, urine output \<0.5 mL/kg/h in more than 6 hours was accepted as oliguria. Also, we found that there was no difference in ICU mortality when HD was started on the basis of this criterion.

A direct association between increased ICU mortality and volume overload of patients has been known for a long time. Therefore, some studies have suggested that HD be started when volume overload is \>10% of the body weight and is unresponsive to diuretic treatment.^[@ref4]^ Hypervolemia was assessed in our study periodically, and it was accepted as an important criterion for HD initiation. Nevertheless, our results demonstrated no effect on ICU mortality.

Ostermann et al.^[@ref8]^ reported increased mortality in patients in whom HD was started with a pH\< 7.2. The threshold level for pH was considered 7.2 in our study. Mortality was similar in the groups of patients in whom HD was commenced with pH levels lower or higher than this level. However, the rate of mortality increased in the patients in whom HD was initiated when the HCO3 level was \<15 mEq/L in blood gas analysis.

The RIFLE and AKIN classification systems have been drawn upon to determine the prognosis of AKI. Nonetheless, they are also currently utilized to determine the timing of RRT. Bagshaw et al.^[@ref13]^ suggested that in the presence of severe AKI (i.e., RIFLE category failure or AKIN category III) and/or rapidly deteriorating kidney function, RRT initiation be considered, particularly if there was failure to respond to initial therapy.

Hoste et al.^[@ref14]^ found that of those developing RIFLE class risk, 56% progressed to either class injury or failure, and of those developing RIFLE class injury, 36% progressed to RIFLE class failure. The patients in RIFLE class failure had a worse clinical outcome, characterized by a 2.7- (95% CI=2.0--3.6) fold increased risk of hospital death and longer durations of stay in both ICU and hospital. Yet, of these RIFLE class failure patients, only 14.2% received HD. However, no specific analysis was performed in their study to explore whether the higher mortality for that group (RIFLE class failure) was modified by earlier HD initiation.

Shiao et al.^[@ref7]^ evaluated the effects of early and late RRT initiation according to the RIFLE classification. Mortality was lower in the patients in whom RRT was started early (43% vs. 75%; P=0.002) in their study, which chimes in with our study.

Bell et al.^[@ref15]^ stratified their study population by RIFLE class at the time of HD initiation and found that those in RIFLE class failure had considerably higher 30-day mortality than those in whom RRT was initiated in either RIFLE class risk or injury (adjusted HR=3.4, 95% CI=1.2--9.3, crude 30-day mortality =57.9% for failure vs. 23.5% for risk vs. 22.0% for injury).

There are some limitations in our study. Firstly, it is a retrospective study. Secondly, it is a single-center study. Thirdly, the study group is very small. Fourthly, all the patients in the study population are medical patients, not traumatic or surgical patients. For all these reasons, the results obtained from this study cannot be generalized. Fifthly, we calculated the estimated GFR with the Cockcroft--Gault formula. This formula is less valuable, but easy to calculate at bedside. The use of this formula may reduce the dependability of the GFR calculation. However, we did not use the estimated GFR to classify the patients according to RIFLE. Despite these limitations, our study is an important study in that it demonstrates the importance of the RIFLE classification in early HD initiation and its relation to ICU mortality.

Conclusion {#sec1-5}
==========

In critically ill patients with AKI, the RIFLE/AKIN criteria can provide the possibility of a more quantitative characterization of the timing of HD initiation.
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